PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028

PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028

Report Format: PDF+Excel | Report ID: SR112023A7070
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global PEGylated Proteins Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 PEGylation Reagents    
           6.1.2.2 PEGylation Kits    
        6.1.3 Market Forecast
    6.2    Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Protein Type
    7.1    Colony Stimulating Factors
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Interferons
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Erythropoietin
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    mAbs
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Recombinant Factor VII
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Application
    8.1    Cancer Treatment
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hepatitis
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Chronic Kidney Diseases
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Hemophilia
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Multiple Sclerosis
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Gastrointestinal Disorders
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9   Market Breakup by End User
    9.1    Pharmaceutical and Biotechnology Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Contract Research Organizations
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Academic and Research Institutes
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  Drivers, Restraints, and Opportunities
    11.1    Overview
    11.2    Drivers
    11.3    Restraints
    11.4    Opportunities
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abcam plc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Biomatrik Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Creative PEGWorks
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Iris Biotech GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    JenKem Technology USA Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Laysan Bio Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    NOF America Corporation (NOF Corporation)
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Profacgen
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Thermo Fisher Scientific Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2022
Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2022
Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2022
Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2022
Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2022
Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: China: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: India: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: France: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2022
Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million US$), 2023-2028
Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: PEGylated Proteins Market: Competitive Structure
Table 8: Global: PEGylated Proteins Market: Key Players

PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028
Select License Type



Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More